Analyst Ratings For Halyard Health (NYSE:HYH)
Today, Halyard Health (NYSE:HYH) stock received an upgrade by Stephens from Equal Weight to Overweight.
There are 2 hold ratings, 2 buy ratings on the stock.
The current consensus rating on Halyard Health (NYSE:HYH) is Buy (Score: 2.50) with a consensus target price of $39.33 per share, a potential 5.63% downside.
Some recent analyst ratings include
- 8/3/2017-Stephens Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
- 1/6/2017-JMP Securities was Downgraded by analysts at JMP Securities from a “Outperform ” rating to a ” Market Perform” rating. They now have a $38.00 price target on the stock.
- 12/15/2016-Deutsche Bank AG was Downgraded by analysts at Deutsche Bank AG from a “Buy ” rating to a ” Hold” rating. They now have a $35.00 price target on the stock.
- 12/18/2015-KeyCorp initiated coverage with a Sector Weight rating.
- 10/12/2015-Morgan Stanley was Downgraded by analysts at Morgan Stanley from a “Equal Weight ” rating to a ” Underweight” rating. They now have a $27.00 price target on the stock.
Recent Insider Trading Activity For Halyard Health (NYSE:HYH)
Halyard Health (NYSE:HYH) has insider ownership of 1.30% and institutional ownership of 91.23%.
- On 9/4/2015 Robert E Abernathy, CEO, bought 10,000 with an average share price of $31.06 per share and the total transaction amounting to $310,600.00. View SEC Filing
- On 9/1/2015 Steven E Voskuil, CFO, bought 1,000 with an average share price of $30.00 per share and the total transaction amounting to $30,000.00. View SEC Filing
Recent Trading Activity for Halyard Health (NYSE:HYH)
Shares of Halyard Health closed the previous trading session at 42.69 up +1.01 2.42% with 1,012,472 shares trading hands.
